Conference Coverage

Apixiban for VTE reduces subsequent hospitalizations

Publish date: April 17, 2014

 

AT ACC 14

The AMPLIFY trial was sponsored by Bristol-Myers Squibb and Pfizer. Dr. Johnson reported having no financial conflicts.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

FDA expands uses for cardiac resynchronization devices
MDedge Internal Medicine
ACC/AHA cardiovascular risk equations get a thumbs-up
MDedge Internal Medicine
Intervention manages cardiac patients with depression, anxiety
MDedge Internal Medicine
Post-MI beta-blockers: Less is more
MDedge Internal Medicine
Diet, exercise in prediabetes may prevent long-term progression and mortality
MDedge Internal Medicine
Insertable monitor reveals AF in 30% of cryptogenic stroke patients
MDedge Internal Medicine
Life partner provides better heart failure outcomes
MDedge Internal Medicine
Complication rates decline among diabetes patients
MDedge Internal Medicine
When low HDL means ‘no sweat’
MDedge Internal Medicine
Marriage protects against vascular disease
MDedge Internal Medicine